PhRMA Funnels Millions to Groups Fighting Drug Pricing Reforms
The pharma lobby gave more than $16 million in 2022 to advocacy groups, many of them ostensibly “grassroots,” that are battling the Medicare drug price negotiations now underway.
Medicare
Novo Nordisk Lobbies Up to Win Medicare Coverage of Its Weight Loss Drugs
The maker of Ozempic and Wegovy has recently hired a dozen new lobbyists to work on the issue of obesity and medication coverage.
Schumer Took a $66k Bundle of Checks From the Health Insurance Industry’s Top Lobbyist
The bundle was given as the health insurance industry was lobbying against Medicare dental, vision, and hearing coverage being included in the Build Back Better Act.
